4,551
Views
18
CrossRef citations to date
0
Altmetric
Commentary

Making vaccines “on demand”

A potential solution for emerging pathogens and biodefense?

, , , , , , & show all
Pages 1877-1884 | Received 20 May 2013, Accepted 02 Jul 2013, Published online: 22 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Anne S. De Groot & Lenny Moise. (2016) Innovation, urgency and acceptance at the 9th Vaccine Renaissance. Human Vaccines & Immunotherapeutics 12:12, pages 3186-3188.
Read now
Anne S. De Groot, Leonard Moise, David Olive, Leo Einck & William Martin. (2016) Agility in adversity: Vaccines on Demand. Expert Review of Vaccines 15:9, pages 1087-1091.
Read now
Amy B Papaneri, Reed F Johnson, Jiro Wada, Laura Bollinger, Peter B Jahrling & Jens H Kuhn. (2015) Middle East respiratory syndrome: obstacles and prospects for vaccine development. Expert Review of Vaccines 14:7, pages 949-962.
Read now
Jeffrey B Ulmer, Monique K Mansoura & Andrew J Geall. (2015) Vaccines ‘on demand’: science fiction or a future reality. Expert Opinion on Drug Discovery 10:2, pages 101-106.
Read now
Frances E Terry, Leonard Moise, Rebecca F Martin, Melissa Torres, Nils Pilotte, Steven A Williams & Anne S De Groot. (2015) Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases. Expert Review of Vaccines 14:1, pages 21-35.
Read now

Articles from other publishers (13)

Maria E. Tsoumani, Chrysa Voyiatzaki & Antonia Efstathiou. (2023) Malaria Vaccines: From the Past towards the mRNA Vaccine Era. Vaccines 11:9, pages 1452.
Crossref
Beatriz C. Fialho, Leandro Gauss, Priscila F. Soares, Maurício Z. Medeiros & Daniel P. Lacerda. (2023) Vaccine Innovation Meta-Model for Pandemic Contexts. Journal of Pharmaceutical Innovation.
Crossref
Yadollah Omidi, Mohammad M. Pourseif, Hossein Omidian & Jaleh Barar. 2022. Nanoengineering of Biomaterials. Nanoengineering of Biomaterials 437 468 .
R. C. Sobti, Mamtesh Kumari, Mandakini Singhla & Ranjana Bhandari. 2022. Biomedical Translational Research. Biomedical Translational Research 3 15 .
Yang HU, Ming-shu WANG, An-chun CHENG, Ren-yong JIA, Qiao YANG, Ying WU, Ma-feng LIU, Xin-xin ZHAO, De-kang ZHU, Shun CHEN, Sha-qiu ZHANG, Yin WANG, Qun GAO, Xu-min OU, Sai MAO, Xing-jian WEN, Zhi-wen XU, Zheng-li CHEN, Ling ZHU, Qi-hui LUO, Bin TIAN, Lei-chang PAN, Mujeeb Ur REHMAN, Yun-ya LIU, Yan-ling YU, Ling ZHANG & Xiao-yue CHEN. (2020) Alphaherpesvirus-vectored vaccines against animal diseases: Current progress. Journal of Integrative Agriculture 19:8, pages 1928-1940.
Crossref
Afsoon Asadzadeh, Saba Pakkhoo, Mahsa Mirzaei Saeidabad, Hero Khezri & Reza Ferdousi. (2020) Information technology in emergency management of COVID-19 outbreak. Informatics in Medicine Unlocked 21, pages 100475.
Crossref
Roman Kogay & Christian Schönbach. 2019. Encyclopedia of Bioinformatics and Computational Biology. Encyclopedia of Bioinformatics and Computational Biology 952 971 .
Hai Yen Lee, Mun Peak Nyon & Ulrich Strych. (2016) Vaccine Development Against Middle East Respiratory Syndrome. Current Tropical Medicine Reports 3:3, pages 80-86.
Crossref
A. V. Kolesnikov, A. V. Kozyr, L. G. Shemyakin, LA. .. Lisitskaya, M. A. Marin, A. K. Ryabko & LA. .. Dyatlov. (2016) SYNTHETIC BIOLOGY AS AN INSTRUMENT FOR DEVELOPMENT OF INNOVATIVE VACCINES FOR PROPHYLAXIS OF BACTERIAL INFECTIONS. Journal of microbiology, epidemiology and immunobiology 93:4, pages 105-115.
Crossref
Prachiti Afley, Sudhir K. Dohre, G. B. K. S. Prasad & Subodh Kumar. (2015) Prediction of T cell epitopes of Brucella abortus and evaluation of their protective role in mice. Applied Microbiology and Biotechnology 99:18, pages 7625-7637.
Crossref
Zhiqiang Duan, Houqiang Xu, Xinqin Ji & Jiafu Zhao. (2015) Recombinant Newcastle disease virus-vectored vaccines against human and animal infectious diseases. Future Microbiology 10:8, pages 1307-1323.
Crossref
Christopher M. Coleman, Ye V. Liu, Haiyan Mu, Justin K. Taylor, Michael Massare, David C. Flyer, Gregory M. Glenn, Gale E. Smith & Matthew B. Frieman. (2014) Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice. Vaccine 32:26, pages 3169-3174.
Crossref
Anne S De Groot, Phoebe De Groot & Yongqun He. (2014) ICoVax 2013: The 3rd ISV Pre-conference Computational Vaccinology Workshop. BMC Bioinformatics 15:S4.
Crossref